HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Osteo-Bi-Flex Extensions Feature Willow Bark, Fruit Chew Delivery Form

This article was originally published in The Tan Sheet

Executive Summary

Rexall Sundown will add four new products to its Osteo-Bi-Flex joint health supplement line in July, including a Fast-Acting Plus Willow Bark formula.

You may also be interested in...



Osteo-Bi-Flex Relaunch To Be Backed By $15 Mil. Ad Spend

Rexall Sundown is planning a $15 mil. ad campaign to support the relaunch of its Osteo-Bi-Flex joint health supplement franchise, according to the firm

Twinlab Energy Fuel Line Provides Women With Low-Fat Offerings

Twinlab plans to roll out its Energy Fuel line of shakes, carbonated drinks, mints and capsules to food, drug and mass outlets nationwide in September.

Natrol, Weider Seek To Raise Bar At Expo West

Natrol is turning toward different delivery vehicles such as nutritional bars and soft chews to help the firm reverse relatively stagnant supplement sales.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel